| No of patients | Average age | Sex (male,%) | Hepatitis C (%) | Alcoholism (%) | Alcoholism+hepatocellular carcinoma (%) | No of medications on discharge | No basiliximab | Only 1 dose | 2 doses | |
|---|---|---|---|---|---|---|---|---|---|---|
| 2013 | 33 | 56.4 | 75.8 | 36.4 | 24.2 | 15.2 | 11.2 | 20 (60%) | 2 (6.1%) | 11 (33.3%) |
| 2014 | 38 (4 Exitus) | 55.2 | 76.3 | 26.3 | 23.7 | 23.7 | 10.9 | 3 (7.9%) | 17 (44.7%) | 17 (44.7%) |